Bicycle Therapeutics PLC (ADR)

General ticker "BCYC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.3B

Bicycle Therapeutics PLC (ADR) follows the US Stock Market performance with the rate: 18.4%.

Estimated limits based on current volatility of 3.3%: low 14.33$, high 15.63$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [10.47$, 22.78$]
  • 2024-12-30 to 2025-12-30 estimated range: [10.13$, 21.81$]

Financial Metrics affecting the BCYC estimates:

  • Negative: Non-GAAP EPS, $ of -5.13 <= 0.10
  • Negative: Operating profit margin, % of -87.56 <= 1.03
  • Negative: Operating cash flow per share per price, % of -9.60 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term BCYC quotes

Long-term BCYC plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $11.70MM $14.46MM $26.98MM
Operating Expenses $77.31MM $131.12MM $216.92MM
Operating Income $-65.62MM $-116.65MM $-189.95MM
Non-Operating Income $-2.86MM $2.41MM $10.74MM
Interest Expense $2.98MM $3.34MM $3.26MM
R&D Expense $44.88MM $81.61MM $156.50MM
Income(Loss) $-68.48MM $-114.24MM $-179.21MM
Taxes $-1.66MM $-1.52MM $1.46MM
Profit(Loss) $-66.82MM $-112.72MM $-180.66MM
Stockholders Equity $346.25MM $270.78MM $370.93MM
Inventory $0.00MM $0.00MM $0.00MM
Assets $479.79MM $410.61MM $595.34MM
Operating Cash Flow $-14.79MM $-86.11MM $-60.63MM
Capital expenditure $2.03MM $18.99MM $2.93MM
Investing Cash Flow $-2.03MM $-18.99MM $-2.93MM
Financing Cash Flow $320.73MM $6.69MM $250.03MM
Earnings Per Share* $-2.67 $-3.80 $-5.08

* EPS are Split Adjusted, recent splits may be reflected with a delay.